NCT02842762

Brief Summary

This study evaluates the usefulness of 3D echocardiography to guide pacemaker therapy in the operating room in cardiac surgical patients. Each patient will serve as his own control, following a paired design.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 20, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 25, 2016

Completed
8 months until next milestone

Study Start

First participant enrolled

March 20, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2017

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2018

Completed
Last Updated

April 12, 2018

Status Verified

April 1, 2018

Enrollment Period

9 months

First QC Date

July 20, 2016

Last Update Submit

April 11, 2018

Conditions

Keywords

Echocardiography, Three-dimensionalCardiac Surgical ProceduresCardiac Pacing, ArtificialAnesthesia

Outcome Measures

Primary Outcomes (1)

  • Left ventricular systolic dyssynchrony index (SDI)

    For each segment of 16 segments excluding the apical cap in a standard 17-segment model, the time to reach regional minimal volume is calculated as a fraction of the total cardiac cycle (RR interval) and expressed as a percentage.10 The standard deviation of these measurements is defined as the SDI. Three-dimensional SDI is therefore the dispersion time to reach the minimum systolic volume (as recommended).

    Intraoperative, end of cardiac surgery (duration 10 minutes)

Secondary Outcomes (3)

  • Ventricular volumes and ejection fraction

    Intraoperative, end of cardiac surgery (duration 10 minutes)

  • LVOT blood flow

    Intraoperative, end of cardiac surgery (duration 10 minutes)

  • Presence and severity of mitral regurgitation

    Intraoperative, end of cardiac surgery (duration 10 minutes)

Study Arms (2)

Non-paced

SHAM COMPARATOR

* cardiac surgery * 3D TEE measurements of systolic dyssynchrony * right ventricular epicardial pacemaker lead (off)

Procedure: cardiac surgeryDevice: 3D TEEDevice: Pacemaker lead

Paced

EXPERIMENTAL

The patient is randomized to the order of measurements taken, and serves as his own control. * cardiac surgery * 3D TEE measurements of systolic dyssynchrony * right ventricular epicardial pacemaker lead (on)

Device: Right ventricular epicardial pacingProcedure: cardiac surgeryDevice: 3D TEEDevice: Pacemaker lead

Interventions

The patient's own heart rate at that moment will be the starting point for the study. Right ventricle pacing will be instituted by selecting a rate that is 5 beats above the patient's own heart rate. We will use a stepwise approach where we increase the pacermaker's rate with steps of 5 beats until we have 100% capture of the pacemaker beats. After waiting for at least one minute of pacing we will obtain a set of measurements.

Paced

Elective cardiac surgery, with use of cardiopulmonary bypass.

Non-pacedPaced
3D TEEDEVICE

Intraoperatively, all patients will be monitored by means of TEE

Also known as: three-dimensional transesophageal echocardiography
Non-pacedPaced

All patients will have a epicardial pacemaker lead in situ.

Non-pacedPaced

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patient scheduled to undergo elective cardiac surgery by means of full sternotomy and use of cardiopulmonary bypass
  • Preoperative moderate to good LV function, ejection fraction \> 30%
  • Age \> 18 yrs. old
  • Preoperative sinus rhythm
  • Pacemaker lead inserted by cardiac surgeon during surgery
  • Underlying sinus rhythm after cardiopulmonary bypass before the end of surgery
  • Able to understand written and verbal patient information
  • Signed informed consent

You may not qualify if:

  • Emergency cardiac surgery
  • Minimally invasive surgery
  • Contraindication to TEE
  • Redo surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital - London Health Sciences Centre

London, Ontario, N6A 5A5, Canada

Location

Related Publications (4)

  • Wolber T, Haegeli L, Huerlimann D, Brunckhorst C, Luscher TF, Duru F. Altered left ventricular contraction pattern during right ventricular pacing: assessment using real-time three-dimensional echocardiography. Pacing Clin Electrophysiol. 2011 Jan;34(1):76-81. doi: 10.1111/j.1540-8159.2010.02908.x. Epub 2010 Oct 14.

    PMID: 20946287BACKGROUND
  • Kapetanakis S, Kearney MT, Siva A, Gall N, Cooklin M, Monaghan MJ. Real-time three-dimensional echocardiography: a novel technique to quantify global left ventricular mechanical dyssynchrony. Circulation. 2005 Aug 16;112(7):992-1000. doi: 10.1161/CIRCULATIONAHA.104.474445. Epub 2005 Aug 8.

    PMID: 16087800BACKGROUND
  • Alwaqfi NR, Ibrahim KS, Khader YS, Baker AA. Predictors of temporary epicardial pacing wires use after valve surgery. J Cardiothorac Surg. 2014 Feb 12;9:33. doi: 10.1186/1749-8090-9-33.

    PMID: 24521215BACKGROUND
  • Bethea BT, Salazar JD, Grega MA, Doty JR, Fitton TP, Alejo DE, Borowicz LM Jr, Gott VL, Sussman MS, Baumgartner WA. Determining the utility of temporary pacing wires after coronary artery bypass surgery. Ann Thorac Surg. 2005 Jan;79(1):104-7. doi: 10.1016/j.athoracsur.2004.06.087.

    PMID: 15620924BACKGROUND

MeSH Terms

Interventions

Cardiac Surgical ProceduresDevice Lead Extraction

Intervention Hierarchy (Ancestors)

Cardiovascular Surgical ProceduresSurgical Procedures, OperativeThoracic Surgical ProceduresDevice Removal

Study Officials

  • Suzanne Flier, MD MSc

    London Health Sciences Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Model Details: Sequence of measurements, during sinus rhythm and during pacing is randomized.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 20, 2016

First Posted

July 25, 2016

Study Start

March 20, 2017

Primary Completion

December 12, 2017

Study Completion

August 1, 2018

Last Updated

April 12, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations